A current evaluation of the safety of angiotensin receptor blockers an
Links shared publicly online about this topic.
- 272total visits
A current evaluation of the safety of angiotensin receptor blockers an
Peer reviewed article authored by (Siragy HM). Read article or submit your manuscript for publishing.
View full resource at dovepress.com
Tags: Safety
Most Recently Shared on May 23, 2011 at 7:02 pm By:
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors. http://bit.ly/iD98aC
FDA announces ongoing safety review of olmesartan
endocrinetoday.com — “The FDA is evaluating data from two clinical trials in which patients with type 2 diabetes assigned olmesartan, an angiotensin II receptor blocker,” View full resource at endocrinetoday.com
Most Recently Shared on June 11, 2010 at 4:48 pm By:
FDA announces ongoing safety review of olmesartan http://ow.ly/1Xj8f
Advertisement
